United-Guardian's President, Donna Vigilante, expressed optimism for 2024, citing new orders of Renacidin, customers beginning to restock, and ongoing distributor negotiations as potential drivers for growth.

United-Guardian's President is pleased with the decision to raise the dividend, stating it will still enable the company to retain more earnings to support 2024 growth targets. The company seeks to balance capital needs with stockholder interests.

Donna Vigilante, President of United-Guardian, praised Ms. Kolinski's appointment, citing her vast experience in commercial development, distribution management, and sales and marketing of personal care ingredients as a valuable asset for the company's growth plan.